Sanford Jeames is a research advocate and a patient advocate. In this Voices on Cancer post, he describes the critical roles he plays to help researchers, clinicians, and communities understand the human impact of cancer.
making a difference
As National Family Caregivers Month approaches, Dr. Hillard writes about why he thinks cancer caregivers should receive their own day of recognition.
October is National Breast Cancer Awareness Month. In this month’s From the Editor’s Desk, Dr. Schapira talks about the different ways in which we can all make a difference.
GIST advocate Norman Scherzer describes how he became involved in advocacy and shares a word of advice for when the going gets tough.
At the 2016 ASCO Annual Meeting, Vice President Joe Biden talked about the Moonshot Initiative and what the future of cancer research offers.
The Brown family turned their son’s cancer journey into a mission to create standards for the psychosocial care of children with cancer and their families. In this podcast, they discuss that journey and what steps are still needed.
How well do you know your co-workers? Rachel Rieger shares her experience after learning a co-worker had twice been through breast cancer.
Cancer does funny things to one’s sense of time. In this post, Margaret Zuccotti talks about how her diagnosis, treatment, and long-term survival of metastatic inflammatory breast cancer caused her to look at her calendar differently.
When Randy Hillard was diagnosed with metastatic stomach cancer in 2010 he was treated with a drug that increased overall survival to an average of 13 months. Now, nearly 5 years later, his unexpected survival has led to some unexpected issues.
In January, Randy Hillard was part of the U.S. Food and Drug Administration committee that considered the first application for a “biosimilar” medication. In this guest post, he describes patients’ role in the drug approval process and how the committee’s decision could influence cancer care in the future.